Found: 71
Select item for more details and to access through your institution.
AI‐guided histopathology predicts brain metastasis in lung cancer patients.
- Published in:
- Journal of Pathology, 2024, v. 263, n. 1, p. 89, doi. 10.1002/path.6263
- By:
- Publication type:
- Article
Incidence and risk factors for bone metastases at presentation in solid tumors.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1392667
- By:
- Publication type:
- Article
A Phase I trial of weekly docetaxel and topotecan for solid tumors.
- Published in:
- Acta Oncologica, 2008, v. 47, n. 2, p. 311, doi. 10.1080/02841860701560340
- By:
- Publication type:
- Article
A phase II study of topotecan and docetaxel in patients with sensitive relapse small cell lung cancer.
- Published in:
- Acta Oncologica, 2008, v. 47, n. 1, p. 152, doi. 10.1080/02841860701418853
- By:
- Publication type:
- Article
Drug delivery and toxicity of adjuvant chemotherapy for non-small cell lung cancer (NSCLC): Washington University experience.
- Published in:
- Acta Oncologica, 2007, v. 46, n. 6, p. 869, doi. 10.1080/02841860701218667
- By:
- Publication type:
- Article
Management of patients with advanced non-small cell lung cancer: role of gefitinib.
- Published in:
- Biologics: Targets & Therapy, 2010, v. 4, p. 83
- By:
- Publication type:
- Article
A Review of Epidermal Growth Factor Receptor/HER2 Inhibitors in the Treatment of Patients with Non-Small-Cell Lung Cancer.
- Published in:
- Chinese Journal of Lung Cancer, 2010, v. 13, n. 4, p. 363, doi. 10.3779/j.issn.1009-3419.2010.04.18
- By:
- Publication type:
- Article
DGIdb: mining the druggable genome.
- Published in:
- Nature Methods, 2013, v. 10, n. 12, p. 1209, doi. 10.1038/nmeth.2689
- By:
- Publication type:
- Article
Non-small-cell Lung Cancer With Brain Metastasis at Presentation.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Efficacy and Safety Results From a Phase II, Placebo-Controlled Study of Onartuzumab Plus First-Line Platinum-Doublet Chemotherapy for Advanced Squamous Cell Non-Small-Cell Lung Cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Exploratory Subset Analysis of African Americans From the PointBreak Study: Pemetrexed-Carboplatin-Bevacizumab Followed by Maintenance Pemetrexed-Bevacizumab Versus Paclitaxel-Carboplatin-Bevacizumab Followed by Maintenance Bevacizumab in Patients With Stage IIIB/IV Nonsquamous Non-Small-Cell Lung Cancer.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Exploratory Subset Analysis of African Americans From the PointBreak Study: Pemetrexed- Carboplatin-Bevacizumab Followed by Maintenance Pemetrexed-Bevacizumab Versus Paclitaxel-Carboplatin-Bevacizumab Followed by Maintenance Bevacizumab in Patients With Stage IIIB/IV Nonsquamous Non-Small-Cell Lung Cancer.
- Published in:
- Clinical Lung Cancer, 2015, v. 16, n. 3, p. 200, doi. 10.1016/j.cllc.2014.11.004
- By:
- Publication type:
- Article
A phase I study of temsirolimus and thoracic radiation in non--small-cell lung cancer.
- Published in:
- 2014
- By:
- Publication type:
- journal article
A Phase I Study of Temsirolimus and Thoracic Radiation in Non-Small-Cell Lung Cancer.
- Published in:
- Clinical Lung Cancer, 2014, v. 15, n. 2, p. 119, doi. 10.1016/j.cllc.2013.11.007
- By:
- Publication type:
- Article
Summary Report From the 13<sup>th</sup> Annual Targeted Therapies of the Treatment of Lung Cancer Meeting.
- Published in:
- Clinical Lung Cancer, 2014, v. 15, n. 1, p. 16, doi. 10.1016/j.cllc.2013.11.010
- By:
- Publication type:
- Article
Summary Report From the 13(th) Annual Targeted Therapies of the Treatment of Lung Cancer Meeting.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Summary of Presentations from the 46th Annual Meeting of the American Society of Clinical Oncology (2010): Focus on Developmental Therapeutics Related to Lung Cancer.
- Published in:
- Clinical Lung Cancer, 2011, v. 12, n. 2, p. 94, doi. 10.1016/j.cllc.2011.03.003
- By:
- Publication type:
- Article
Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer.
- Published in:
- Clinical Lung Cancer, 2010, v. 11, n. 5, p. 311, doi. 10.3816/CLC.2010.n.039
- By:
- Publication type:
- Article
A Review of Epidermal Growth Factor Receptor/HER2 Inhibitors in the Treatment of Patients With Non–Small-Cell Lung Cancer.
- Published in:
- Clinical Lung Cancer, 2010, v. 11, n. 1, p. 8, doi. 10.3816/CLC.2010.n.001
- By:
- Publication type:
- Article
Treatment Rationale and Study Design for the PointBreak Study: A Randomized, Open-label Phase III Study of Pemetrexed/Carboplatin/Bevacizumab Followed by Maintenance Pemetrexed/Bevacizumab Versus Paclitaxel/Carboplatin/Bevacizumab Followed by Maintenance Bevacizumab in Patients with Stage IIIB or IV Nonsquamous Non–Small-Cell Lung Cancer
- Published in:
- Clinical Lung Cancer, 2009, v. 10, n. 4, p. 252, doi. 10.3816/CLC.2009.n.035
- By:
- Publication type:
- Article
Progress in the Treatment of Metastatic Non–Small-Cell Lung Cancer: Slow but Steady!
- Published in:
- Clinical Lung Cancer, 2009, v. 10, n. 4, p. 260, doi. 10.3816/CLC.2009.n.036
- By:
- Publication type:
- Article
Combined KRAS-MAPK pathway inhibitors and HER2-directed drug conjugate is efficacious in pancreatic cancer.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-46811-w
- By:
- Publication type:
- Article
Improving Outcomes in Non-Small Cell Lung Cancer: A Closer Look at Molecular Markers and Histology.
- Published in:
- Journal of Managed Care Medicine, 2014, v. 17, p. 6
- By:
- Publication type:
- Article
Update on Current and Novel Treatment Strategies in Non-Small Cell Lung Cancer.
- Published in:
- Journal of Managed Care Medicine, 2011, v. 14, n. 4, p. 64
- By:
- Publication type:
- Article
Bone metastases in lung cancer. Potential novel approaches to therapy.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Clinical Applications of The Cancer Genome Atlas Project (TCGA) for Squamous Cell Lung Carcinoma.
- Published in:
- Oncology (08909091), 2013, v. 27, n. 9, p. 899
- By:
- Publication type:
- Article
Influenza Vaccination in Patients With Cancer: an Overview.
- Published in:
- Oncology (08909091), 2010, v. 24, n. 12, p. 1167
- By:
- Publication type:
- Article
Time to Move Beyond Clinical and Pathologic Classification of BAG.
- Published in:
- Oncology (08909091), 2010, v. 24, n. 10, p. 900
- By:
- Publication type:
- Article
Lung Cancer in 'Never-Smokers': A Unique Entity.
- Published in:
- Oncology (08909091), 2010, v. 24, n. 1, p. 29
- By:
- Publication type:
- Article
The Role of Surgery in Stage III Non-Small-Cell Lung Cancer.
- Published in:
- Oncology (08909091), 2008, v. 22, n. 5, p. 557
- By:
- Publication type:
- Article
Lung Cancer-Related Brain Metastases: Further Considerations.
- Published in:
- Oncology (08909091), 2008, v. 22, n. 2, p. 178
- By:
- Publication type:
- Article
Untangling the evolutionary roots of lung cancer.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-10879-6
- By:
- Publication type:
- Article
Establishment of Novel Neuroendocrine Carcinoma Patient-Derived Xenograft Models for Receptor Peptide-Targeted Therapy.
- Published in:
- Cancers, 2022, v. 14, n. 8, p. 1910, doi. 10.3390/cancers14081910
- By:
- Publication type:
- Article
nab -Paclitaxel Plus Durvalumab in Patients With Previously Treated Advanced Stage Non-small Cell Lung Cancer (ABOUND.2L+).
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.569715
- By:
- Publication type:
- Article
Translatability of findings from cynomolgus monkey to human suggests a mechanistic role for IL-21 in promoting immunogenicity to an anti-PD-1/IL-21 mutein fusion protein.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1345473
- By:
- Publication type:
- Article
Management of patients with non-small cell lung cancer and poor performance status.
- Published in:
- Current Treatment Options in Oncology, 2003, v. 4, n. 1, p. 55, doi. 10.1007/s11864-003-0031-x
- By:
- Publication type:
- Article
Lack of trastuzumab activity in nonsmall cell lung carcinoma with overexpression of erb-B2The following institutions participated in this study: CALGB Statistical Center, Durham, NC (Stephen George, Ph.D.; supported by grant CA336) Christiana Care Health Services, Inc. Community Cooperative Oncology Program (CCOP), Wilmington, DE (Stephen Grubbs, M.D; supported by grant CA45418); Dartmouth Medical SchoolNorris Cotton Cancer Center, Lebanon, NH (Marc S. Ernstoff, M.D.; supported by grant CA04326); Duke University Medical Center, Durham, NC (Jeffrey Crawford, M.D.; supported by grant CA47577); Greenville CCOP, Greenville, SC (Jeffrey Giguere, M.D.); Long Island Jewish Medical Center, Lake Success, NY (Marc Citron, M.D.; supported by grant CA11028); Rhode Island Hospital, Providence, RI (William Sikov, M.D.; supported by grant CA08025); Southeast Cancer Control Consortium Inc. CCOP, Goldsboro, NC (James N. Atkins, M.D.; supported by grant CA45808); State University of New York Upstate Me
- Published in:
- Cancer (0008543X), 2005, v. 103, n. 8, p. 1670
- By:
- Publication type:
- Article
Phase I dose and sequencing study of pegylated liposomal doxorubicin and docetaxel in patients with advanced malignancies.
- Published in:
- Cancer (0008543X), 2003, v. 98, n. 3, p. 610
- By:
- Publication type:
- Article
A survey of Internet utilization among patients with cancer.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Assessing quality of life following neoadjuvant therapy for early stage non-small cell lung cancer (NSCLC): results from a prospective analysis using the Lung Cancer Symptom Scale (LCSS).
- Published in:
- 2009
- By:
- Publication type:
- journal article
In vivo assessment of tumor hypoxia in lung cancer with [sup 60] Cu-ATSM.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2003, v. 30, n. 6, p. 844, doi. 10.1007/s00259-003-1130-4
- By:
- Publication type:
- Article
A Phase I Trial of Temsirolimus and Pemetrexed in Patients with Advanced Non-Small Cell Lung Cancer.
- Published in:
- Chemotherapy (0009-3157), 2016, v. 61, n. 3, p. 144, doi. 10.1159/000442147
- By:
- Publication type:
- Article
A Phase I Trial of Sunitinib and Rapamycin in Patients with Advanced Non-Small Cell Lung Cancer.
- Published in:
- Chemotherapy (0009-3157), 2013, v. 59, n. 1, p. 8, doi. 10.1159/000348584
- By:
- Publication type:
- Article
A Phase I Study of Pegylated Liposomal Doxorubicin and Irinotecan in Patients with Solid Tumors.
- Published in:
- Chemotherapy (0009-3157), 2009, v. 55, n. 6, p. 441, doi. 10.1159/000264925
- By:
- Publication type:
- Article
A Phase I Study of Bexarotene and Rosiglitazone in Patients with Refractory Cancers.
- Published in:
- Chemotherapy (0009-3157), 2008, v. 54, n. 3, p. 236, doi. 10.1159/000140468
- By:
- Publication type:
- Article
A Phase I Study of Docetaxel and Bexarotene.
- Published in:
- Chemotherapy (0009-3157), 2008, v. 54, n. 2, p. 125, doi. 10.1159/000119706
- By:
- Publication type:
- Article
Biomarker-Driven Staging—Are We There Yet?
- Published in:
- 2019
- By:
- Publication type:
- Opinion
MicroRNA profiling and prediction of recurrence/relapse-free survival in stage I lung cancer.
- Published in:
- Carcinogenesis, 2012, v. 33, n. 5, p. 1046, doi. 10.1093/carcin/bgs100
- By:
- Publication type:
- Article
Transcriptome sequencing reveals altered long intergenic non-coding RNAs in lung cancer.
- Published in:
- Genome Biology, 2014, v. 15, n. 8, p. 1, doi. 10.1186/s13059-014-0429-8
- By:
- Publication type:
- Article
Phase I dose-escalation studies of roniciclib, a pan-cyclin-dependent kinase inhibitor, in advanced malignancies.
- Published in:
- 2017
- By:
- Publication type:
- journal article